[논문]경피적 관상동맥중재술 후 재협착 예방에 대한 한약의 효과 : 무작위배정 대조군 임상연구에 대한 체계적 문헌고찰 및 메타분석

허나연; 안수빈; 김홍준; 장인수

doi:10.22246/jikm.2023.44.3.387

경피적 관상동맥중재술 후 재협착 예방에 대한 한약의 효과 : 무작위배정 대조군 임상연구에 대한 체계적 문헌고찰 및 메타분석
Effect of Herbal Medicines on Preventing Restenosis After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis of Randomized Controlled Trials 원문보기

대한한방내과학회지 = The journal of internal Korean medicine, v.44 no.3, 2023년, pp.387 - 401

허나연 (우석대학교 한의과대학 내과학교실) , 안수빈 (우석대학교 한의과대학 내과학교실) , 김홍준 (우석대학교 한의과대학 방제학교실) , 장인수 (우석대학교 한의과대학 내과학교실)

Abstract ▼ AI-Helper

Objective: This study was conducted to investigate the preventive effect of herbal medicines on restenosis after percutaneous coronary intervention (PCI) by reviewing randomized controlled trials (RCTs). Methods: RCTs were searched for herbal medicine treatment after PCI using eight online databases (PubMed, CNKI, Wanfang, J-STAGE, OASIS, ScienceON, KTKP, and KISS). Studies that confirmed restenosis through coronary angiography at follow-up were selected according to the inclusion and exclusion criteria. The primary outcome was the restenosis rate, and the secondary outcome was the angina recurrence rate. Data were extracted from the final selected studies according to the research methodology and then analyzed with Review Manager 5.4.1. Study quality was assessed using Cochrane's risk-of-bias (RoB) tool. Results: Of the 252 papers obtained through the primary search, nine studies that met the selection criteria were finally selected. In these nine studies, herbal medicine combined with western medicine was used for the experimental group, and western medicine treatment was used alone for the control group. The meta-analysis result revealed that the restenosis rate and angina recurrence rate were significantly lower in the experimental group than in the control group (RR=0.34, 95% CI: 0.22-0.53, p<0.00001, I2=0% and RR=0.47, 95% CI: 0.29-0.78, p=0.004, I2=0%, respectively). Furthermore, the quality of studies assessed by Cochrane's RoB was low. Conclusions: This study showed that the combined treatment of herbal medicine and western medicine was effective in preventing restenosis and angina after PCI. As the number of papers included in this study was small, a large number of high-quality clinical studies should be considered in the future.

주제어

표/그림 (8)

그림 Fig. 1. PRISMA flow diagram of the study selection process. n : number of records
표 Table 1. Characteristics of Included 9 RCTs with Herbal Medicine Treatment for Preventing Restenosis after PCI
표 Table 2. Effect and Composition of Herbal Medicine Prescriptions Used in the Concomitant Treatment with Western Medicine for Preventing Restenosis after PCI
그림 Fig. 2. Risk of bias graph of included 9 RCTs with herbal medicine treatment for preventing restenosis after PCI.
그림 Fig. 3. Risk of bias summary of included 9 RCTs with herbal medicine treatment for preventing restenosis after PCI.
그림 Fig. 4. Forest plot of comparison : herbal medicine and western medicine (HM+WM) vs Western medicine (WM), outcome : restenosis after percutaneous coronary intervention.
그림 Fig. 5. Forest plot of comparison : herbal medicine and western medicine (HM+WM) vs Western medicine (WM), outcome : angina recurrence after percutaneous coronary intervention.
그림 Fig. 6. Funnel plot of comparison : herbal medicine and western medicine (HM+WM) vs Western medicine (WM), outcome : restenosis after percutaneous coronary intervention.

참고문헌 (38)

Sasaki S. Cardiovascular and neurological medicine？in Korean medicine II. Seoul: Woori medical？books; 2016, p. 134-47.
Statistics Korea. 2021 annual report on the？causes of deaths statistics [Internet]. Daejeon？(KR): Statistics Korea; 2021 [cited 2021 Sep？26]. Available from: https://www.index.go.kr/unity/potal/main/EachDtlPageDetail.do?idx_cd1012.
Roth GA, Mensah GA, Johnson CO, Addolorato？G, Ammirati E, Baddour LM, et al. Global？burden of cardiovascular diseases and risk？factors, 1990-2019: Update from the GBD 2019？Study. J Am Coll Cardiol 2020;76(25):2982-3021.

상세보기
Ang YX, Khudzari AZM, Ali MSM. Non-invasive？treatment for coronary in-stent restenosis via？wireless revascularization with nitinol active Stent.？IEEE Trans Biomed Eng 2021;68(12):3681-9.

상세보기
Lawton JS, Tamis-Holland JE, Bangalore S,？Bates ER, Beckie TM, Bischoff JM, et al. 2021？ACC/AHA/SCAI guideline for coronary artery？revascularization: a report of the american？college of cardiology/american heart association？joint committee on clinical practice guidelines.？Circulation 2022;145(3):e18-e114.

상세보기
Lansky A, Grubman D, Scheller B. Paclitaxelcoated balloons: a safe alternative to drug-eluting？stents for coronary in-stent restenosis. Eur Heart？J 2020;41(38):3729-31.

상세보기
Iakovou I, Schmidt T, Bonizzoni E, Ge L,？Sangiorgi GM, Stankovic G, et al. Incidence,？predictors, and outcome of thrombosis after？successful implantation of drug-eluting stents.？JAMA 2005;293(17):2126-30.

상세보기
Rosand J, Eckman MH, Knudsen KA, Singer？DE, Greenberg SM. The effect of warfarin and？intensity of anticoagulation on outcome of？intracerebral hemorrhage. Arch Intern Med 2004;164(8):880-4.

상세보기
Bae SE, Kim SE, Jung SA, Yoon SY, Shim KN,？Jung HK, et al. The effect of aspirin alone or？aspirin plus additional antiplatelets therapy on？upper gastrointestinal hemorrhage. Korean J？Gastroenterol 2011;57(4):213-20.
Song SH, Choi JA. A study on the trend of？world traditional medicine and key area of？traditional Korean medicine(TKM) R&D. Korea？J Orient Med 2010;16(1):101-9.
Min SW, Kim HK, Moon JS, Kim YS, Park？JY, Jeong JC. Case report of Korean medical？treatment of chest pain after percutaneous？coronary intervention. J Int Korean Med 2021;42(2):184-96.
Hui J, Yuan R, Li P, Xin Q, Miao Y, Shen？X, et al. Efficacy and safety of different courses？of Tongxinluo capsule as adjuvant therapy for？coronary heart disease after percutaneous coronary？intervention: a systematic review and meta-analysis of randomized controlled trials. J Clin？Med 2022;11(11):2991.
Xu G, Lin B, Mao Z, Zhang M. Meta-analysis？of the clinical efficacy and safety of Xiongshao？capsule in the treatment of in-stent restenosis？after PCI. Chin J Integr Med Cardio/Cerebrovas？Dis 2022;20(22):4045-51.
Chen Y, Xue C, Yang D, Yao R, Li L, Huang？L. Evaluating the advantages of traditional？Chinese medicine for supplementing qi and？promoting blood circulation method in the？prevention and treatment of ISR after PCI？based on meta-analysis. Chin J Integr Med？Cardio/Cerebrovas Dis 2022;20(14):2497-507.
Du Y, Song C, Jiaerken A, Wang X. Meta-analysis？on efficacy of yiqi huoxue Chinese drugs in the？treatment of coronary heart disease after coronary？revascularization. Medicinal Plant 2019;10(03):69-76.
Luo X, Huang B. Meta-analysis of clinical？effect of combined phlegm-eliminating and？blood-stasis-removing herbs on restenosis after？PCI. Guiding J Tradit Chin Med Pharmacol？2020;26(11):131-7.
Ren Y, Chen K, Ruan X, Wu H, Ou A, Wang？Y, et al. Systematic review of randomized？controlled trials on preventing and treating？restenosis after percutaneous coronary intervention？with Chinese medicine. Chin J Integr Med？2008;07:597-601.
Wu J, Zhao L, Lin K, Lu L, Luo C. Chinese？herbal medicines for restenosis after percutaneous？coronary intervention: a meta-analysis of？randomized controlled trials. J Altern Complement？Med 2019;25(10):983-92.

상세보기
Liu S. Application effect of Tongxinluo capsule？combined with clopidogrel and aspirin in？patients with coronary heart disease after PCI.？Clin Res Pract 2019;4(19):127-31.
Zhou X, Li L, Yang K, Sun L. Clinical？observation of Gualou Xiebai granule in the？treatment of PCI postoperative restenosis in？soft plaque of coronary artery with syndrome？of phlegm-dampness blocking. Shanghai J Tradit？Chin Med 2017;51(11):41-4.
Hu X, Cao Z, Wang S, Wang J. Clinical observation？of Yan 's Wenyang Huoxue recipe in the？prevention and treatment of restenosis after？percutaneous coronary intervention. Shanghai J？Tradit Chin Med 2017;51(04):59-62.
Liu L, Jiang T. The influence of Tongxinluo？capsule and atorvastatin on in-stent restenosis？and inflammatory factors after percutaneous？coronary intervention. Chin J Integr Med Cardio/Cerebrovas Dis 2017;15(07):769-71.
Wang K, Yu Z. Clinical effect of Huxinkang？tablets in treatment of restenosis after percutaneous？coronary interventionin patients with coronary？heart disease. Hunan J Tradit Chin Med 2016;32(12):7-9.
Sun Q. Efficacy of integrated traditional Chinese？and western medicine in prevention of restenosis？after percutaneous coronary intervention. J New？Chin Medicine 2016;48(02):31-3.
Tang M, Peng X, Yan S. Effects of prostaglandin？E1 combined with Tongxinluo capsule on PCI？inflammatory factor and restenosis. J Hunan？Univ Chin Med 2015;35(06):54-6.
Niu X, Zhao Y, Zhang X, Li D, Xu Y, Cui C.？41 Cases of restenosis in patients with coronary？heart disease after PCI with Jingqi Danshen？Yin. J Tradit Chin Med 2012;53(17):1503-4.
Cheng S, Fang X, He J, Wang Q. Effect of？Anxin granule on the restenosis after percutaneous？coronary intervention. J Tradit Chin Med 2010;51(07):603-6.
Kim SY, Park JE, Seo HJ, Lee YJ, Jang HB,？Son HJ, et al. NECA's guidance for undertaking？systematic reviews and meta-analyses for？intervention. Seoul: National evidence-based？healthcare collaborating agency; 2011, p. 65-70,？172-5.
Kim WJ, Cho JH, Jung JH, Lee MK, Yoon？JS, Ahn YS, et al. Clinical comparison of？drug-eluting stents and bare metal stents in？large coronary arteries. Korean J Med 2011;80(6):664-71.
Kim MS, Dean LS. In-stent restenosis. Cardiovasc？Ther 2011;29(3):190-8.
Kim YS, Kim KK, Hwang IC. Aspirin usage based？on evidence for the prevention of cardio-cerebrovascular disease. Korean J Fam Med？2009;30(4):249-60.
Sasaki S. Cardiovascular and neurological medicine？in Korean medicine I. Seoul: Woori medical？books; 2016, p. 117-33.
Berman NG, Parker RA. Meta-analysis: neither？quick nor easy. BMC Med Res Methodol 2002;2(1):10.

상세보기
Kim YJ, Park OJ. A survey on patients' compliance？with follow-up coronary angiogram after coronary？intervention. Korean J Adult Nurs 2000;12(1):30-9.
Wang Z, Gong C, Li Z. Research progress of the？molecular mechanism of Tongxinluo capsule？treatment in cardio-cerebrovascular diseases.？Chin J Emerg Med 2010;19(12):2112-4.
Fan X. Thirty-one cases of modified Gualou？Xiebai Banxia decoction for treatment of the？coronary heart disease with chronic heart failure？with phlegm-turbid obstruction, qi stagnation？and blood stasis type. Henan Tradit Chin？Med 2012;32(09):1122-3.
He Q, Wang J. Research on TCM syndromes？and diagnosis of patients after percutaneous？coronary intervention based on cluster analysis.？J Tradit Chin Med 2008;10:918-21.
Lee CH. Standards of medical care in percutaneous？coronary intervention. Korean J Med 2012;83(2):233-5.

저자의 다른 논문 :

표제어: PCR

동의어: Packet Collision Rate

용어 설명 출처 목록 (6)

용어 설명: PCR은 세균 특이성이 있는 primer를 이용하여 적은 수의 세균이 있을지라도 쉽게 검출할 수 있는 유용한 방법이며, 이를 이용하여 구강 내 치면세균막이나 타액에서 직접 세균을 검출할 수 있게 되었다[8].

내보내기 구분	파일저장 인쇄 메일전송
구성항목	기본정보 상세정보 관리번호, 논문명, 저널/프로시딩명, 저자 , 발행년, 권, 호, 시작페이지, 끝페이지, 발행기관 관리번호, 논문명, 대등논문명, 저자 , 저널/프로시딩명, 발행기관, 발행년, 발행언어, 권, 호, 시작페이지, 끝페이지, ISBN, ISSN, 주제분야, 키워드, 초록(한글), 초록(영문), 저자(소속기관)
저장형식	Text(ASCII format) Excel format RefWorks Direct Export RIS format (for Reference Manager, ProCite, EndNote), Scholar's Aids, Mendeley
메일정보	받는사람 (필수) @ 보내는사람 (선택) @ 제목 내용 KISTI 검색결과 이메일 서비스
안내	총 건의 자료가 검색되었습니다. 다운받으실 자료의 인덱스를 입력하세요. (1-10,000) 검색결과의 순서대로 최대 10,000건 까지 다운로드가 가능합니다. 데이타가 많을 경우 속도가 느려질 수 있습니다.(최대 2~3분 소요) 다운로드 파일은 UTF-8 형태로 저장됩니다. 파일의 내용이 제대로 보이지 않을실 때는 웹브라우저 상단의 보기 -> 인코딩 -> 자동선택 여부를 확인하십시오. ~ Text(ASCII format) Excel format